Facebook Linkedin RSS Twitter Youtube
Home 2024

SARS-CoV-2

Mitigating Risks in Oligonucleotide Therapeutic Development
Sponsored

Mitigating Risks in Oligonucleotide Therapeutic Development

Severe COVID-19 Lung Disease Linked to Ferroptosis
Infectious Diseases

Severe COVID-19 Lung Disease Linked to Ferroptosis

Universal Vaccine Strategy Boosts Body’s RNAi Response to Viruses
Drug Discovery

Universal Vaccine Strategy Boosts Body’s RNAi Response to Viruses

Viral RNA-Based Diagnostics: Nanopore System May Outperform PCR
Featured

Viral RNA-Based Diagnostics: Nanopore System May Outperform PCR

Dried Blood COVID Dx, Cryo-Shocked Tumor Cell Delivery Vehicles, Verve Halts Trial, Iambic Starts Trial, and Diagonal Therapeutics Launches
Artificial Intelligence

Dried Blood COVID Dx, Cryo-Shocked Tumor Cell Delivery Vehicles, Verve Halts Trial, Iambic Starts Trial, and Diagonal Therapeutics Launches

Metal-Organic Nanoparticles Enable Better Vaccine Delivery, Stronger Immune Response
Coronavirus

Metal-Organic Nanoparticles Enable Better Vaccine Delivery, Stronger Immune Response

Cas12a-Based Diagnostic Test Strips Likened to “PCR in Your Pocket”
Featured

Cas12a-Based Diagnostic Test Strips Likened to “PCR in Your Pocket”

Plant Molecular Farming as a Novel Vaccine Production Method
Infectious Diseases

Plant Molecular Farming as a Novel Vaccine Production Method

Moderna Gets Back to Its Roots, Form Bio and Ginkgo Bioworks Team Up, and Under-the-Radar Rare Autoimmune Diseases
Bioprocessing

Moderna Gets Back to Its Roots, Form Bio and Ginkgo Bioworks Team Up, and Under-the-Radar Rare Autoimmune Diseases

Yale Receives Grant to Fund Long COVID Research
Coronavirus

Yale Receives Grant to Fund Long COVID Research

123...48Page 1 of 48
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.